BERLIN — For men with high-risk biochemically recurrent prostate cancer, adding enzalutamide (Xtandi) to standard androgen ...
CHICAGO, Oct. 21, 2025 (GLOBE NEWSWIRE) -- VelocityEHS, the global leader in EHS solutions and a pioneer in practical, human-centered AI for workplace safety, today announced new AI-powered ...
The Festival of Accord Dreamspell event will bring lots of new armor sets to Monster Hunter Wilds, as well as a fresh ...
Enterprise AI keeps hitting the same wall - not enough people who know how to use it. Databricks is spending $10 million to ...
The Subject Expert Committee (SEC), functioning under the Central Drugs Standard Control Organisation (CDSCO), has opined ...
Eight artificial intelligence and machine-learning startups will take the stage Oct. 29 in Bentonville for the 2025 Fuel ...
For years, we believed the Himalayas were a climatic sanctuary—untouched, pristine, and resilient to the turbulence of ...
In a major development for diabetes care in India, Dr. Reddy's Labs has got the go-ahead from the Subject Expert Committee ...
Endo announces the U.S. launch of a generic version of RAVICTI® (glycerol phenylbutyrate), marking a significant milestone as a new generic treatment option for patients with ...
BERLIN -- Combining enzalutamide (Xtandi) with androgen deprivation therapy (ADT) significantly improved overall survival (OS ...
There are so many upcoming Marvel movies and shows on the way that keeping up can be hard work. The MCU has been in full ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback